TGFB1 and diabetes mellitus: Wang et al. [82] reported that the CV extract with a polysaccharide content of 17.74% (CV/W) could significantly reduce cardiac fibrosis in diabetes rats and inhibit transforming growth factor β1(TGF-β1)/Smad signal transduction, and could also significantly reduce cardiac inflammation in diabetes rats, significantly improving cardiac dysfunction.